NewsFeed
December, 2025
December 2025
M T W T F S S
1234567
891011121314
15161718192021
22232425262728
293031  
Alberto Sifuentes Giraldo: Key Insights on Antiphospholipid Syndrome From Recent Study
Dec 18, 2025, 13:34

Alberto Sifuentes Giraldo: Key Insights on Antiphospholipid Syndrome From Recent Study

Alberto Sifuentes Giraldo, Rheumatologist at Nuestra Señora de Sonsoles Hospital, shared a post on LinkedIn about a paper by Pedro Gaspar et al. published in Rheumatology:

“Sustained loss of antiphospholipid (aPL) positivity (≥2 negative tests ≥12 months apart) is associated with a substantial reduction in recurrent thrombosis risk, as demonstrated by a cohort study of 116 thrombotic aPL syndrome patients (1084 patient-years follow-up):

aPL negativization occurred in 32%. Primary aPL syndrome patients favored it; triple positivity hindered it.

39% of patients had recurrent thrombosis despite therapy; this was predicted by older age, arterial events, and persistent triple positivity.

In patients achieving sustained aPL negativization, recurrence risk dropped 88% afterward (adjusted HR 0.12, 95% CI 0.05–0.58; p=0.006).

These findings support the value of serial aPL monitoring in clinical management of thrombotic aPL syndrome.

Gaspar Pedro, Cruz-Machado Ana Rita, Ana Mafalda Abrantes, et al. Loss of antiphospholipid antibody positivity decreases the risk of recurrent thrombosis in thrombotic antiphospholipid syndrome. Rheumatology (Oxford), 2025.”

Title: Loss of antiphospholipid antibody positivity decreases the risk of recurrent thrombosis in thrombotic antiphospholipid syndrome

Authors: Pedro Gaspar, Ana Rita Cruz-Machado, Ana Mafalda Abrantes, Filipa Costa, Inês Parreira, Ana Rita Lopes, Ryan Costa-Silva, Ana Teodósio Chícharo, Joana Rosa Martins, João Pedro Marques, Diogo Santos , Vasco C Romão, Luis Graca, João E Fonseca

Read the full article.

Alberto Sifuentes Giraldo

Stay updated on all scientific advances in the field of fertility with Fertility News.